If you’ve ever been unlucky enough to need continuous EKG monitoring, you’ve probably used: a Holter monitor. It’s like wearing an 80’s Walkman made of metal with a bunch of wires going from there to your chest. If that sounds uncomfortable, and like you don’t get much sleep or enjoy the showers for the two weeks it takes you to wear it, you’re neatly the use case for the mawi Heart patch. The company has just released its product, a two-lead heart monitor that can be read in real time.
There are consumer-grade products that can take ECG readings, including the Withings ScanWatch (and its fancier-looking brother, the ScanWatch Horizon), and there are other patches on the market, such as the Zio patchbut Mawi claims to have done something unique and suggests that the Heart Patch is the first single-use heart monitor ever to hit the market.
The company describes it as “a portable, wireless solution” and goes on to suggest that the disposable nature of the device is an advantage; it means cardiologists can perform tests on as many patients as they need without having to wait for reusable Holter monitors to return from other patients and be cleaned and serviced between uses.
“Holter monitors aren’t great,” Andrew Klymenko, the CEO of Mawi, said dryly in an interview we held last week, explaining that the existing solutions have a tendency to peel, peel and allergic reactions. thus reducing monitoring time. As a result, Mawi claims that more than 50% of arrhythmias go undetected. Equally bad: Patients have to wait up to a month to receive the results.
Mawi Heart Patch, the company claims, can be applied in less than a minute and you can live like normal while wearing it.
“Patients can shower, sleep, exercise,” says Klymenko, stressing that it is possible to wear the patch and live all aspects of life as normal. “Sex is a big and important part of life and patients can have sex normally when they wear the Mawi patch.”
“Cardiovascular diseases pose the greatest risk to our long-term health and are the leading cause of death worldwide. With a lack or ineffective monitoring that often proves to be critical, many of these deaths could be avoided with the right preventive measures,” Klymenko said. “Too often, patients don’t realize the severity of their symptoms before it’s too late. Many patients using the Mawi Heart Patch look healthy, exercise daily and show no signs of illness, yet have potentially fatal heart disease. We are on a mission to prevent the ‘silent killers’ of the heart, and we are already partnering with like-minded clinics who are achieving amazing results.”
The patch connects to a smartphone device in the doctor’s office. That device sends the data to the cloud, where an AI analyzes the results and takes a closer look at anything unusual for the cardiologists. The process is indeed very fast, which means that patients can get feedback and next steps for their treatment.
“Lin less than 24 hours [the doctors] have a very detailed, accurate and actionable report,” says Klymenko, suggesting that doctors can focus on treatment, rather than spend a lot of time analyzing data. “It only takes two seconds to manage.”
The company currently has about 30 employees, mainly concentrated in Europe. Klymenko himself is from Ukraine and his team is spread all over the world, including teams in Thailand and in the US. To date, the company has started.
Mawi won’t share exactly how many devices it has in the field, but Klymenko admits they ship “thousands of devices” every month to customers in the US, EU and the Middle East.
The devices must be prescribed by a doctor, and the price depends a lot on the medical insurance and medical care system you work on, but Klymenko says the devices typically cost “less than $250 per exam.”